ROS1 and neoplasm: This can be exploited by the immunohistochemical detection of oncogenic ROS1 in NSCLC tumor cells [76]; however, recent data have questioned the specificity of the available ROS1 antibodies and advocated for the use of reflex NGS for the detection of ROS1 alterations [77].